FYPERIX COMBO 402 MG/361,8 MG SPOT-ON SOLUTION FOR EXTRA LARGE DOGS
FYPERIX COMBO 402 MG/361,8 MG SPOT-ON SOLUTION FOR EXTRA LARGE DOGS
Authorised
- Fipronil
- Methoprene
Product identification
Medicine name:
FYPERIX COMBO 402 MG/361,8 MG SPOT-ON SOLUTION FOR EXTRA LARGE DOGS
Amflee combo, 402 mg/361,8 mg täpilahus eriti suurtele koertele
Active substance:
- Fipronil
- Methoprene
Target species:
-
Dog
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Fipronil402.00milligram(s)1.00Pipette
-
Methoprene361.80milligram(s)1.00Pipette
Pharmaceutical form:
-
Spot-on solution
Withdrawal period by route of administration:
-
Cutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AX65
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- Tad Pharma GmbH
- Krka d.d. Novo Mesto
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1961
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0333/005
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Estonia
-
Germany
-
Greece
-
Italy
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 25/03/2022
How useful was this page?: